These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38563804)

  • 1. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection.
    Bader El Din NG; Farouk S
    J Interferon Cytokine Res; 2024 Jun; 44(6):233-243. PubMed ID: 38563804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.
    Dominguez-Molina B; Machmach K; Perales C; Tarancon-Diez L; Gallego I; Sheldon JL; Leal M; Domingo E; Ruiz-Mateos E
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV J6/JFH1 tilts the capability of myeloid-derived dendritic cells to favor the induction of immunosuppression and Th17-related inflammatory cytokines.
    Fang Z; Zhu K; Guo N; Zhang N; Guan M; Yang C; Pan Q; Wei R; Yang C; Deng C; Liu X; Zhao P; Leng Q
    Pharm Res; 2015 Mar; 32(3):741-8. PubMed ID: 23619596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-26 inhibits hepatitis C virus replication in hepatocytes.
    Beaumont É; Larochette V; Preisser L; Miot C; Pignon P; Blanchard S; Hansen BT; Dauvé J; Poli C; Poranen MM; Lamourette P; Plaisance M; Morel A; Fickenscher H; Jeannin P; Roingeard P; Delneste Y
    J Hepatol; 2022 Apr; 76(4):822-831. PubMed ID: 34952035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
    Li H; Huang MH; Jiang JD; Peng ZG
    World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.
    Nishitsuji H; Funami K; Shimizu Y; Ujino S; Sugiyama K; Seya T; Takaku H; Shimotohno K
    J Virol; 2013 Jul; 87(14):8169-78. PubMed ID: 23678168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
    Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
    mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of interferon inductors on infection induced by hepatitis C virus and activity of mRNA cytokines in cell cultures SW-13 and MT-4].
    Narovlianskiĭ AN; Deriabin PG; Vershinina MIu; Mezentseva MV; Ershov FI
    Vopr Virusol; 2002; 47(6):17-21. PubMed ID: 12508677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.
    Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA;
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1770-81. PubMed ID: 23663030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokine mediators in acute inflammation and chronic course of viral hepatitis].
    Missale G; Ferrari C; Fiaccadori F
    Ann Ital Med Int; 1995; 10(1):14-8. PubMed ID: 7727201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
    Casey JL; Feld JJ; MacParland SA
    Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection.
    Carreca AP; Gaetani M; Busà R; Francipane MG; Gulotta MR; Perricone U; Iannolo G; Russelli G; Carcione C; Conaldi PG; Badami E
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications.
    Hammerstad SS; Blackard JT; Lombardi A; Owen RP; Concepcion E; Yi Z; Zhang W; Tomer Y
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1157-68. PubMed ID: 31784757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory status in human hepatic cirrhosis.
    Martínez-Esparza M; Tristán-Manzano M; Ruiz-Alcaraz AJ; García-Peñarrubia P
    World J Gastroenterol; 2015 Nov; 21(41):11522-41. PubMed ID: 26556984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.
    Li K; Li NL; Wei D; Pfeffer SR; Fan M; Pfeffer LM
    Hepatology; 2012 Mar; 55(3):666-75. PubMed ID: 22030901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis.
    Pollmann J; Götz JJ; Rupp D; Strauss O; Granzin M; Grünvogel O; Mutz P; Kramer C; Lasitschka F; Lohmann V; Björkström NK; Thimme R; Bartenschlager R; Cerwenka A
    J Hepatol; 2018 Mar; 68(3):421-430. PubMed ID: 29100993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.